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Abstract	  
One of the emerging complications prevalent in hospital settings is Clostridium 
difficile associated disease (CDAD). The outbreaks of CDAD in the past decade have 
been attributed to the hypervirulent and epidemic CD 027. This particular strain 
expresses elevated levels of enterotoxin TcdA and cytotoxin TcdB in addition to a 
third ADP-ribosylating binary toxin known as CDT. The aim of this project is to 
evaluate the role of CDT in the pathogenesis of CDAD that is especially manifested 
by the hypervirulent 027.  
CDT has been shown to have an enterotoxic activity in rabbits but no evident 
pathogenic role in hamsters. CDT+ strains do however induce the colonization of CD 
in hamsters. Despite these conflicting observations in the animal models, it could be 
suggested that CDT has a supplementary role to TcdA and TcdB in the pathogenesis 
of CDAD. This may be due to closer interaction and colonization of CD cells with the 
host epithelium supported by CDT which could enhance the toxic effect of TcdA and 
TcdB. Furthermore, the elevated increase in expression of TcdA and TcdB may be 
due to the truncation of tcdC that is a negative regulator of the two toxins and the use 
of fluoroquinolones or ethanol increases the incidence and recurrence of 027. Further 
experimental studies on the combinatory role of CDT along with the other two toxins 
may elucidate on the definite role of CDT in the pathogenesis of CDAD. 
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1.	  Introduction	  
Clostridium difficile (CD) is a gram-positive anaerobic spore forming bacterium that 
has been recognized as a major cause of nosocomial diarrhea (Voth and Ballard, 
2005) and pseudomembranous colitis (Bartlett et al., 1978). Antimicrobial drugs are 
known as the major risk factors in the virulence of CD associated disease (CDAD) by 
disturbing the normal intestinal microbiota (Deneve et al., 2008). Transmission of CD 
mostly occurs in clinical and hospital settings where admission of antibiotics and 
contamination of environment by CD spores are commonly present (Johal et al., 
2004; Cartman et al., 2010). The major virulence factors of CD are the enterotoxin 
TcdA and cytotoxin TcdB, that glucosylate small GTPases of the Ras subfamily. This 
inactivation leads to disruption of the actin cytoskeleton and ultimately apoptosis. A 
third toxin, CDT, has been shown to be produced by some strains of CD. CDT is a 
binary toxin composed of two components CDTa and CDTb that are involved in the 
enzymatic activity and receptor binding respectively. The presence of both 
components is essential for the activity of CDT. Like other Bacillus and Clostridia 
toxins, CDT is involved in ADP-ribosylation of actin and ultimate disruption of the 
host’s cytoskeleton (Barth et al., 2004).  
Recently, a dramatic increase in frequency, resistance and severity of CDAD has been 
observed in multiple clinical outbreaks around the world. The largest outbreaks 
started in Pittsburg, Pennsylvania in 2001 (Muto et al., 2005; McEllistrem et al., 
2005) followed by Québec, Canada in 2003 (Loo et al., 2005). The global extent of 
the spread has gone further with reports of several outbreaks in Europe including 
Denmark (Anlonso et al., 2005; Bacci et al., 2009; Indra et al., 2009). These regional 
outbreaks resulted in increased mortality and colectomies. In the case of Québec, 
Canada (Loo et al., 2005) the mortality rate of CDAD increased to 6.9% in 
comparison to the very low mortality rate of <2% in the 1990s (Blossom and 
McDonald, 2007). This global epidemic hypervirulent strain has been characterized as 
North American Pulsed Field Type 1 (NAP1) or PCR ribotype 027. In addition to 
TcdA and TcdB, it produces the binary toxin CDT and carries a frame shift mutation 
in the tcdC gene that negatively regulates the expression of TcdA and TcdB (Martin 
et al., 2008). NAP1/027 has been shown to produce 16 fold more TcdA and 23 fold 
more TcdB in vitro (Warny et al., 2005). The significance of toxins A and B in 
CDAD is well known but the role of CDT in pathogenesis remains to be elucidated. 
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2.	  Theory	  
 
2.1	  Clostridium	  difficile	  toxins	  
An important factor in the pathogenesis of CDAD is the transcription of different 
toxins.  
Toxins A and B are the major virulence determinants of CD encoded by the tcdA and 
tcdB genes. These two along with three other regulatory genes (tcdR, tcdE and tcdC) 
are positioned at a 19.6 kb pathogenicity locus (PaLoc) on the CD chromosome 
(Figure 1) (Warny et al., 2005). 
 
 
Figure 1: the pathogenicity locus of C. difficile (Warny and Kelly, 2003) 
In the 19.6 kb PaLoc, Toxin A and Toxin B are encoded by tcdA and tdcB genes and tcdR acts as a positive 
regulator of toxin transcription. Moreover tcdC is a putative negative regulator of toxin transcription. The actual 
function of the tcdE gene is uncertain but it may facilitate the release of toxin by membrane lysis. The epidemic 
PCR ribotype 027 strain of CD carries a mutation in tcdC that prevents the expression of TcdC protein and 
therefore result in transcription of tcdA and tcdB. 
Note: tcdR is also noted as tcdD in the litterature. 
 
In addition to TcdA and TcdB, a number of CD strains, including the epidemic PCR 
ribotype 027 (NAP1), produce the binary toxin CDT. The position of the genes that 
encode this toxin is outside of the PaLoc (McDonald et al., 2005; Geric et al., 2006). 
CDT, that is homologous to the iota toxin of C. perfringens E, is comprised of two 
components CDTa (99 kD) and CDTb (48 kD) transcribed by the cdtA and cdtB genes 
(Barth et al., 2004). While the binary toxin has entrotoxic activity in vitro, its role, if 
any, in the pathogenesis of CD is unclear at the moment (Barbut et al., 2005).  
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2.2	  Regulation	  of	  toxin	  expression	  by	  genes	  in	  the	  PaLoc	  region	  
Both tdcA and tcdB are positioned in the PaLoc with a distance of 1400 nucleotide 
away from each other and they are both transcribed in the same direction. In addition 
to these two genes, the PaLoc contains three other open reading frames (ORF) that 
are assumed to regulate the production of the toxins or their release from the cell 
(Hammond and Johnson, 1995). tcdC is placed downstream of tcdA and transcribed 
in the opposite direction to the toxins, it is present in high concentrations in the early 
exponential phase but diminishes later on the stationary phase of growth. Since this 
decline in the expression of TcdC protein is attributed to an increase in the 
expression of TcdA and TcdB, it has been suggested that tcdC acts as a negative 
regulator of the two toxins (Hundsberger et al., 1997). 
In addition to tcdC, tcdD is another ORF that is found within the PaLoc. This gene is 
positioned upstream of tcdB and is therefore expressed with both of the toxin genes. 
Having a similar structure to DNA-binding proteins, TcdD has been shown to amplify 
the expression of the promoter fusion reporter with the promoter binding regions of 
tcdA and tcdB (Monocrief et al., 1997). Other researches (Marvaud et al., 1998; 
Marvaud, Gilbert et al., 1998) support the positive regulatory effect of TcdD on the 
expression of Toxins A and B by indicating that TcdD is homologous to TetR and that 
BotR positively regulates the expression of tetanus and botulinum toxins respectively. 
Moreover, TcdD is also homologous to UviA, which has a regulatory effect on the 
expression of a UV-inducible bacteriocin gene of C. perfringens (Garnier and Cole, 
1988). There is therefore a consensus in the literature that TcdD may act as a positive 
regulator in the expression of Toxins A and B. Mani and Dupuy (2001) have, in 
accordance to this theory, suggested that TcdD may act as an alternative σ-factor for 
RNA-polymerase without binding directly to the promoter regions of tcdA and tcdB 
(Figure 1). The expression of TcdD is shown to be repressed by glucose in growth 
culture (Voth and Ballard, 2005) and is largely increased in the stationary phase of 
growth (Hundsberger et al., 1997). In addition, TcdD auto-regulates its own 
expression in response to different environmental signals, which makes it to be a 
significant positive regulator of the expression of TcdA and TcdB (Mani et al., 2002). 
On the other hand, there are speculations that tcdE, which is located between tcdB and 
tcdA, encodes TcdE that assist the release of TcdA and TcdB by permeabilisation of 
the CD cell wall (Tan et al., 2001). Therefore the expression of toxins appears to be 
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favorably regulated by a decrease in the production of TcdC, increase in the 
production of TcdD and TcdE facilitates release from the cell.  
 
2.3	  Genetics	  and	  biochemistry	  of	  Toxin	  A	  and	  B	  
tcdA and tcdB are relatively large being 8,133 7,098 nucleotides respectively. 
Furthermore, both of the genes have relatively low proportion of G+C content (>28%) 
(Dove et al., 1990; Barosso et al., 1990) that is consistent with the rather low 
proportion of G+C in CD genome (≈29%) (Voth and Ballard, 2005).  
The toxins are largely similar to each other (63%). It has been suggested that the two 
genes encoding the toxins may have had a common ancestor and evolved as a result 
of a gene duplication event due to their proximal position and significant functional 
and sequence homology von Eichel-Streiber et al., 1992). Moreover, both TcdA and 
TcdB use their highly conserved NH2-terminals (N-terminals) to modify identical 
substrates (von Eichel-Streiber et al., 1990), demonstrating a very similar biochemical 
activity and further supporting the hypothesis of gene duplication.  
A number of short and similar sequence of amino acids (AAs) named Combined 
Repetitive Oligopeptides (CROPs) exist in the COOH-terminal (C-terminal) of TcdA 
and TcdB. CROPs are considered to be key players in receptor binding and initial 
interactions with the target cell, although the mechanism in cell binding remains 
unclear. While TcdA has five groups of CROPs ranging from 21 to 50 AAs 
throughout its C-terminal, TcdB also encodes the same number of CROPs where four 
are homologous to the CROPs of TcdA. Yet the CROPs of TcdB tend to be more 
diverse and less frequent than the ones found in TcdA (von Eichel-Streiber et al., 
1992; Voth and Ballard, 2005). 
Apart from the homology between TcdA and TcdB, the toxins have similarity to 
other large toxins as well. TcdB is the most homologous to TcsL with 85% 
homology and 74% identity, where TcsL is the cytotoxin of C. sordellii that 
glycosylates Ras, Rac, Rap and Ral (Voth and Ballard, 2005). TcdB has been shown 
to have cross-reactivity with TcsL specific antiserums (Popoff, 1987). However, 
TcdB and TcsL have different substrate specificity deriving from the major 
differences in their N-terminals (Hoffmann et al., 1998). 
On the other hand, TcdA has significant similarity to TcsH, which is the enterotoxin 
produced by C. sordellii. This similarity is also assessed from the recognition of 
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TcdA and TcsH by each other’s antiserums (Martinez and Wilkins, 1988) supporting 
a close similarity between these toxins. 
A summary of the CD PaLoc genetics and proposed domains of TcdA and TcdB is 
illustrated below (Figure 2). 
 
	  
Figure 2: genetics of C. difficile PaLoc and protein structures of TcdA and TcdB (Voth and Ballard, 2005) 
For arrangement and function of genes in the 19.6 kb PaLoc see Figure 1. A three-domain structure for Toxins A 
and B has been suggested. The glycosyltransferase activity is positioned on the N-terminal of the protein. The 
COOH-terminal contains CROPs that are involved in the receptor binding. Finally, the putative transmembrane 
segment in the middle is assumed to play a role in membrane translocation. 
 
2.4	  Mechanism	  of	  action	  of	  Toxins	  A	  and	  B	  
TcdA and TcdB disrupt the action of the Ras superfamily of small GTPases by 
modifying their active site via glycosylation (Voth and Ballard, 2005) leading to 
disorganization of the actin cytoskeleton causing apoptosis (Figure 3) (Chaves-Olarte 
et al., 1997; Mitchell et al., 1987). In this context, cell with lower level of UDP-
glucose are less susceptible to the toxins (Chaves-Olarte et al., 1996). 
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In order to evoke their cytotoxic effect, the two toxins penetrate the host cell by 
endocytosis provided that the endosome is acidic enough to allow their access into the 
cytosol (Florin and Thelestam, 1983; Henriques et al., 1987). This may be due to 
structural modifications necessary for the toxin where the hydrophobic domain has to 
be exposed before insertion into the target membrane (Qa’Dan et al., 2000).  
In order to penetrate the cell membrane the toxins need to bind to carbohydrate 
receptors.  
The primary target of Toxin A and B is Rho a major regulator of the actin 
cytoskeleton. Rho exists in isoforms A, B and C and is present in every eukaryotic 
cell (Hall, 1990). Rac and Cdc42 are other intracellular GTPases that are targeted by 
both TcdA and TcdB (Chaves-Olarte et al., 1997). In addition to the collapse of the 
actin cytoskeleton, the toxic activity of TcdA and TcdB leads to rounding of the cells, 
membrane blebbing and eventual apoptosis (Voth and Ballard, 2005).  
The target substrates, Rho, Rac and Cdc42 are also involved in regulation of cellular 
events besides the actin cytoskeleton including the regulation of the cell cycle and 
mitogen-activated protein kinase (MAPK) signaling (Figure 5) (Voth and Ballard, 
2005).  
TcdB disrupts the tight junctions of epithelial cells causing increased permeability 
between the epithelium (Voth and Ballard, 2005). Moreover, TcdB affects the level of 
phospholipase A2 activity (Shoshan et al., 1993). Among others the inactivation of 
the Rho proteins by TcdB, inhibits receptor coupled signaling through Phospholipase 
D (Schmidt et al., 1996).  
On the other hand, the inactivation of Rho protein by TcdA leads to an increase in 
permeability of the epithelial layers of the colon (Chen et al., 2002). The elevated 
permeability of the colonic epithelial layers increases the access of 
polymorphonuclear cells to the colonic epithelium leading to the inflammatory 
response seen in pseudomembranous colitis (Figure 4) (Voth and Ballard, 2005). 
Pseudomembranous colitis is an infection of the colon and a cause of diarrhea in 
patients infected with CD.  
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Figure 3: mechanism of action of TcdA and TcdB (Voth and Ballard, 2005) 
TcdA and TcdB enter the cell through receptor-mediated endocytosis by binding themselves to disaccharide or 
other carbohydrates present on the surface of the plasma membrane. The pH of the endosome needs to be acidic in 
order for the toxins to develop a configuration that allows them to enter the cytosol. The toxins then glycosylate 
GTPase (target Rac, Rho and Cdc42) which would inhibit several different functions of these proteins such as the 
regulation of actin cytoskeleton and eventually lead to apoptosis. 
 
 
Figure 4: summary of the effects of TcdA and TcdB on the infected intestinal cells (Voth and Ballard, 2005) 
In epithelial cells of the colon, TcdA and TcdB disrupt the mechanism of cdc42, Rac and Rho ultimately leading to 
apoptosis. TcdB disrupts the tight junctions of epithelial cells causing increased permeability between the 
epithelium. On the other hand, apart from disrupting the tight junctions of the epithelium, TcdA causes neutrophil 
infiltration and production of chemokine, cytokine, reactive oxygen intermediate and substance P. The 
combination of one or more of these activities results in fluid accumulation and inflammatory response in the host 
intestinal cells. 
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Figure 5: overview of the signaling pathways by members of Rho family of GTPases1 
Rho, Rac and Cdcd42 are the members of Rho family of GTPases that are the most targeted by TcdA and TcdB. 
Rho family is itself a member of Ras superfamily of GTPases. Binding of GTP to these small proteins leads to the 
trigger of different signaling pathways in the cell that are mostly involved in the regulation of intracellular actin. 
The distruption of the mechanism of these GTPases by TcdA and TcdB leads the disruption of the actin 
cytoskeleton and apoptosis.  
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2.5	  Genetics	  and	  biochemistry	  of	  the	  binary	  C.	  difficile	  toxin	  
Like all other bacterial binary toxins, CDT is composed of two components CDTa 
and CDTb that are involved in the enzymatic activity and receptor binding (Gilbert et 
al., 2011). The genes encoding CDT have 27-31% G+C content (Popoff, 2000).  
The genetic foundation of the binary CD toxin has been primarily investigated by 
Perelle et al., 1997. This group has cloned and sequenced the CDT locus (Figure 6) of 
the CD strain (CD196). Their findings show that the genes encoding CDT are located 
on a 4277 bp CDT locus containing two ORFs cdtA and cdtB.  
Based on the sequencing of CDT from CD196 strain by Perelle et al. the initiation 
codon of cdtA is located seven nucleotides away from a consensus ribosome-binding 
site (GGGAGGG) extended from 105 to 1487 nucleotide positions. The coding region 
of cdtA shows 84.6% identity compared to the iap gene of the binary C. perfringens 
E. This identity is at 60% for the first 104 nucleotides before the initiation codon in 
cdtA when compared to the corresponding region of iap. Despite the close homology 
observed between the two genes, the inverted repeat present at the transcriptional 
origin site of iap is absent in cdtA. On the other hand, an inverted repeat with ability 
to form a stem-loop structure is present in the 5’ upstream region of cdtA (Figure 6). 
The structure of CDTa (CD196 strain) is deduced to be 460 AAs long (Perelle et al., 
1997). Based on a program by Klein et al. (1985), a signal peptide is formed by 43 
AAs of N-terminal. It has been suggested that K-42-V-43 is the proteolytic cleavage 
site of this signal peptide. The mature CDTa protein would therefore be 418 AAs long 
and have a molecular weight of 47986 Da in accordance to the approximate size of 
the purified native protein (43 kDa), (Popoff et al., 1988).  
The comparison of mature CTDa and Ia indicates a homology of 84.3% between the 
AAs sequences. Moreover, Ia has a similar molecular weight with 47588 Da. On the 
other hand, the isoelectric point (pI) of CDTa is very different from that of Ia (9.34 
and 5.44 respectively) (Perelle et al., 1997).  
Furthermore, similar active sites in both CDTa and Ia are observed. In this context, R-
295, E-378 and E-380 are the three AAs that flank a β-strand to an α-helix and are 
significant in the catalytic activity of Ia (Perelle et al., 1996). In CDTa, R-296, E-379 
and E-381 residues along with the stretch from F-336 to I-354 are the major 
components of the catalytic site (Perelle et al., 1997). 
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cdtB is the second ORF found in the CDT locus downstream of cdtA (Figure 6). This 
gene is 84.1% identical to the ibp gene of the binary C. perfringens E toxin. On the 
other hand the 52 bp intergenic region between cdtA and cdtB is 61.5% and the 106 
bp downstream of cdtB is only 40.8% identical to the corresponding regions outside 
the ibp ORF. GGAGG is a consensus ribosome-binding site that is located 7 bp before 
the initiation codon of cdtB. A terminator sequence other than Rho protein is found in 
the 3’ of the cdtB while no such stem-loop structure is suggested to be present in the 
3’ region of the ibp gene (Perelle et al., 1997).  
Similar to what was observed in CDTa, the 42 AAs in the N-terminal of CDTb form a 
signal peptide (Perelle et al., 1993).  
In both CDTb and Ib, Lys-Glu is a common cleavage site found between the 
precursor form and the signal peptide. CDTb consists of 876 AAs with a predicted 
molecular mass of 98895 Da. This component of CDT shows 81.2% homology to the 
precursor Ib protein. A proteolytic site is assumed to be present on K-209-L-210 
position in the sequence of CDTb (Perelle et al., 1997). 
The hydrophobic sequence K-292 to S-309 in Ib is conserved in the hydrophobic 
sequence K-293 to S-310 in CDTb. It has been suggested that this sequence is 
involved in the translocation of the toxin across the cell membrane by forming a 
transmembrane segment (Perelle et al., 1993). In addition the hydrophobic sequence, 
the ATP/GTP binding site is also conserved in both CDTb and Ib (Perelle et al., 
1997). 
Apart from the analysis of the CD196 binary toxin, other researches on different 
binary C. difficile toxins have been conducted. In a study by Braun et al., 2000, it has 
been shown that a cdtA gene of an isolate from a horse exhibits 98.3% nucleotide and 
99.5% AA identity to that of CD196. On the other hand Chang and Song, 2001, 
isolated a TcdA+ and TcdA- CD strain with a complete set of both cdtA and cdtB 
genes. This strain was named ATCC 8864 or 8864 strain. The two genes encoding the 
binary toxin along with the intergenic sequence showed 99.6% homology to that of 
CD196 reported by Perelle et al. in 1997. The very slight difference between the 
binary toxin operons of the two strains was attributed to an insertion of 9 extra bases 
within the cdtA gene of 8864. Interestingly, this insertion does not affect the 
downstream region of this ORF (Chang and Song, 2001).   
There are significant similarities in the binary toxin genes of CD196 and that of strain 
630 especially in parts of the 5’-end of the cdtA and the 3’-end of the cdtB while 
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approximately 2 kb of the sequence is deleted in strain 630 (Rupnik et al., 2003). The 
2 kb deletion from the reference CD strain VPI 10463 in 8884 strain was also reported 
by Chang and Song 2001, while no binary toxin genes were found in the non-
toxicogenic 8884 strain. Rupnik et al., 2003 reported significant similarity between 
three regions of the truncated binary toxin gene operon of strain 630 to the 
corresponding regions of the binary toxin operon on CD196 (Figure 7). These regions 
included a 164 bp long ‘box 1’ with a homology of 96% to the beginning of cdtA in 
CD196. Chang and Song, 2001 have also reported the 9 base pair insertion at position 
164 of cdtA meaning close homology within cdtA of all three strains (CD196, 164 and 
8864) up to position 164 nt. While in strain 630 the next 104 bp are different from the 
corresponding on CD196, a new homologous region starts thereafter for 260 bp from 
positions 268 to 528 (box 2) with 96% identity to the corresponding sequence on cdtA 
of CD196. The 2068 bp deletion in CdtLoc of strain 630 starts from 529 nt on cdtA to 
1062 nt on cdtB covering regions of both genes and their intergenic sequence. Finally, 
‘box 3’ extends from position 1063 on cdtB till its stop codon at 2631 with a 
homology of 93% to the corresponding region of cdtB on CD196. While the 2 kb 
deletion in the CdtLoc of strain 630 covers part of codon sequence expressing C-
terminal of CDTa essential for catalytic function, it remains unclear whether it could 
affect the cytotoxic activity of the binary toxin in strain 630 (Rupnik et al. 2003). 
Rupnik et al., 2003 also reports a homology within regions outside the coding 
sequence of cdtA and cdtB in 630 and CD196 strains. In this context, it has been 
suggested that the 100 bp upstream of cdtA, and the 103 bp downstream of cdtB are 
respectively 95% and 96% homologous in the two strains. 
In addition to cdtA and cdtB, Carter et al., 2007 reported a third gene cdtR that is 
suggested to encode a response regulator CdtR. It has been shown that CdtR is 
essential for an enhanced expression of a functional binary toxin. An internal deletion 
of cdtR resulted in significant decline in the binary toxin production by C. difficile. 
cdtR and cdtAB are genetically linked on the CdtLoc where cdtR is located in the 5’ 
upstream region of the other two genes. Carter et al. have furthermore shown that 
cdtR was absent in a CD strain that did not carry the intact cdtAB genes or cdtAB 
pseudogenes where the entire CdtLoc is replaced by a conserved 68 bp sequence. 
CdtR is believed to be member of response regulators known as the LytTR family 
(Carter et al., 2007). 
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Figure 6: nucleotide sequence and deduced amino acid translation for CdtLoc of CD196 (Perelle et al., 1997) 
cdtA extend from 105 to 1487 nt encoding CDTa with 460 aa. cdtB from 1539 to 4169 nt encoding CDTb with 876 
aa. The considered ribosome binding sites are underlined. Stop codons are marked by asterisk. The inverted 
repeats are marked with dashed arrow under their sequences. The predicted signal peptides are italic. Boldface is 
used for the predicted CDTb transmembrane segment. The considered ATP/GTP binding domain is also 
underlined. 
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Figure 7: comparison of CdtLoc on C. difficile strain CD196 and strain 630 (Rupnik et al., 2003) 
The genetical structure of C. difficile strain CD196 is compared with that of strain 630. Strain 630 shares three 
regions of homology with strain CD196 within CdtLoc. Box 1 extending from positions 1 to 164 nt shows 96% 
homology with the corresponding region on strain CD196. Box 2 composed of 260 bp and extended from 268 to 
528 nt also shows 96% homology. The 2068 bp deletion includes regions of both genes and their intragenic 
sequences. Box 3, extended from 1063 to 2630 nt position shows 93% homology to the corresponding region on 
strain CD196.  
 
2.6	  Mechanism	  of	  action	  and	  structure	  of	  the	  binary	  C.	  difficile	  toxin	  
2.6.1	  Overview	  
The detailed mechanism of action of binary CD toxin is not well described, but it 
seems reasonable to discuss the mechanism of action of other similar binary toxins. 
The binary toxin of C. perfringens E and that of CD share similar mechanism of 
actions. This similarity extends to other binary bacterial toxins such as C. botulinum 
C2, C. spiroforme CST and Bacillus cereus VIP (Barth et al., 2004).  
In this common mechanism of action (Figure 8), the two components of the binary 
toxin protein have different functions. Component B interacts with specific receptor 
binding sites of target cell in order to provide access for the enzymatic component A 
to the cytosol of the target cell (Marvaud et al., 2001; Gilbert et al., 2007). 
In order to initiate its activity, a precursor B protein undergo proteolysis to generate 
an activated B oligomer. Seven activated B oligomers bind to form a B heptamer. 
The B heptamer interacts with specific receptors on the cell membrane to create a 
complex that acts as a cooperative surface. This surface translocates the enzymatic 
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component A into the cytosol of the target cell through an acidified endosome (Barth 
et al., 2004) (Figure 8). 
Component A inhibits normal cell functions through deactivation of various 
pathways. The primary activity of the enzymatic CDTa, is the mono-ADP-
ribosylation of G-actin that causes the disorder of cytoskeleton and apoptosis (Barth 
et al., 2004). 
 
 
Figure 8: the general mechanism of action in 
bacterial and bacillus binary toxins 
B component precursor undergoes a 
proteolytic cleavage by Trypsin in order to 
generate an activated B (the cleavage of B. 
anthracis PA83 is specifically carried out by 
cell associated furin). The interaction of 
activated B heptamer with specific receptors 
provides biding of the catalytic component A 
and its subsequent entry via acidified 
endosomes. The release of component A into the cytosol of the target cell and its later catalytic functions (mainly 
the ADP-ribosylation of actin) induces cytotoxic effects such as the disruption of the cytoskeleton and apoptosis. 
The attachment, entry and sometimes exist of B heptamer is facilitated through 
clusters of lipid rafts present on the plasma membrane. Lipid rafts are structures or 
micro-domains on the outer cell membrane that have rich contents of cholesterol 
(Simons and Ehehalt, 2002). 
The N-terminal domains of the A and B components interact with each other before 
entry to the cytosol. When bound to the surface receptor, the enzymatic component is 
absorbed through two different pathways. The first pathway involves passage through 
the Golgi apparatus and the Endoplasmic Reticulum (ER) (Barth et al., 2004). This 
pathway, also used by the Cholera toxins, is inhibited by the fungal macrolide 
Brefeldin A, which accumulates proteins within the ER (Chardin and McCormick, 
1999). The second mechanism, which is also adapted by both CDT and iota toxin (C. 
perfringens E), is translocation through acidified endosomes. The transport of vesicles 
from early to later endosomes in this mechanism is carried out by microtubules 
(Schwan et al., 2009; Blöcker et al., 2001). Microtubules are cleaved by Nocodazole; 
a drug that inhibits the transfer of early to late endosomes (Sakai et al., 1991). Similar 
to what was observed in the case of TcdA and TcdB, an acidified endosome is 
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necessary for translocation of the catalytic component. Low pH on the cell surface 
prompts conformational changes in B and facilitates its insertion and the subsequent 
translocation of component A (Blöcker et al., 2001; Blöcker et al., 2003). 
Furthermore, a membrane potential gradient is required for the transportation of C. 
perfringens E iota toxin (Gilbert et al., 2007). 
It is known that the heat shock protein 90 (Hsp90) mediates the transfer of catalytic 
component(s) through the endosomal membrane (Haug et al., 2003). Hsp90 plays a 
vital role in regulation of proteins involved in cell signaling. This ATPase is 
ubiquitous in all eukaryotic cells (Pratt and Toft, 2003). The role of Hsp90 is 
supported by delay in the cytotoxic activity of binary toxins (excluding B. anthracis 
lethal toxin) through inhibitors of Hsp90 such as Geldanamycin or Radicicol (Haug 
and Leemhuis et al., 2003). 
It has been shown that, upon exposure to a low pH, the A fragment of Diphtheria 
toxin (C. diphtheriae) unfolds its structure and passes through toxin produced 
channels in the membrane entering to the cytosol of the target cell (Falnes et al., 
1994). This has lead to the suggestion that the enzymatic component A of all Bacillus 
and Clostridia binary toxins follows the same procedure (Barth et al., 2004).  
Like other Clostridia and Bacillus binary toxins, C. diphtheriae targets the cell 
through ADP-ribosylation mechanism (Falnes et al., 1994). In this context while both 
Geldanamycin and Radicicol are necessary for inhibition of C. diphtheriae 
cytotoxicity, either one of these drugs are sufficient in slowing down the effect of 
CDT, C2 or the iota toxin. Moreover, while the presence of disulfide bonds between 
the A and B fragments of C. diphtheriae has been established, no such bonds have 
been shown to be present on other Bacillus and Clostridia binary toxins, depicting the 
differences in their structures with other binary toxins (Barth et al., 2004). 
It has recently been shown that the C. botulinum C2 and C. perfringens E iota toxins 
enter the cell through a pathway other than clathrin that is regulated by Rho-GDI 
(Gilbert et al., 2011). Clathrin is a protein that creates clathirin coated vesicles for 
translocation of intracellular materials through cytoplasm.   
 
2.6.4	  ADP-­‐ribosylation	  of	  G-­‐actin	  
An advantage in the study of the mechanism of ADP-ribosylation cytotoxic effect is 
that all bacterial toxins with such function (including CDT, C2, CST, iota toxin and 
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VIP) follow similar mechanisms. All toxins use Nicotinamide Adenine Dinucleotide 
(NAD), as their ADP-ribose source. NAD is involved as a reduction/oxidation 
coenzyme in all eukaryotic and prokaryotic cells (Barth et al., 2004).  
ADP-ribosylating toxins are categorized in four different bacterial groups based on 
their intracellular target (Barth et al., 2004): 
1. Elongation factor 2 (C. diphtheriae and P. aeruginosa exotoxin A) 
2. Heterotrimeric G-proteins (B. pertussis, E. coli heat-labile and V. cholera) 
3. Rho and Ras GTPases (C. botulinum and P. aeruginosa C3 and S exoenzymes) 
4. G-actin 
G-actin ADP-ribosylating toxins are: C. botulinum C2 (Reuner et al., 1987), B. cereus 
VIP (Han et al., 1999), C. difficile CDT (Popoff et al., 1988), C. perfringens iota 
(Perelle et al., 1996), and C. spiroforme CST (Popoff and Boquet, 1988). The active 
site of all actin-modifying toxins is located in their C-terminal (Barth et al., 2004). 
The actin modifying ADP-ribosylating toxins are comprised of two groups. The first 
group includes the C2 toxin that specifically targets R-177 (Figure 9) residue of β/γ 
non-muscular and β smooth muscular actins (Aktories et al., 1986; Mauss et al., 1990). 
The second group includes the iota toxins family that target the same AA of all G-actins 
isoforms including α skeletal muscle, α cardiac muscle, gizzard γ smooth muscle, spleen 
β/γ cytoplasmic and aortic α/γ smooth muscle (Mauss et al., 1990).  
It has been shown that the enzymatic activity of the iota toxin is inhibited by EDTA 
chelation following that EDTA chelates divalent cations in interaction with actin and 
thereby deforms the protein. The ADP-ribosylation activity of iota toxin continues even 
at a low temperature of 0 °C but in half of what is observed at 37 °C. Furthermore, the 
activity of C2 and iota toxins is reversed in the presence of excess NAD yielding a 
higher percentage of free actin and NAD. It has also been shown that the addition of 
iota toxin reverses the ADP-ribosylation of platelet actin by C2 verifying that both 
toxins target the same AAs in actin. On the other hand the toxins show different 
substrate specificities since C2 is unable to separate ADP-ribose of a skeletal muscle 
actin having been targeted by the iota toxin (Just et al., 1990).  
While filamentous actin (F-actin) is not a substrate of ADP-ribosylation (Aktories et 
al., 1986), the ADP-ribosylation of globular (G-actin) leads to depolymerization of 
cytoskeleton associated F-actin into monomeric G-actin, thereby increasing the level 
of G-actin by inhibiting the formation of F-actin strands (Aktories et al., 1989). 
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Therefore there would be a disruption in the equilibrium of monomeric G-actin and F-
actin (Wegner and Aktories, 1988; Weigt et al., 1989; Aktories et al., 1989).  
There is evidence for the interaction of ATPase with ADP-ribosylated G-actin (by 
iota toxin) so that the activity of ATPase is inhibited in the process. This leads to a 
decrease in the hydrolysis of ATP and an increase in the rate of ATP exchange 
(Geipel et al., 1989; Geipel et al., 1990).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.6.5	  Structural	  features	  of	  CDTa	  
The structure of CDTa is comprised of an N-terminal and a C-terminal of similar size. 
The N-terminal is involved in interaction with the receptor-binding component. In 
competition with the full length CDTa, the C-terminal has a much less enzymatic 
activity, depicting the significance of the C-terminal in the catalytic function of CDTa 
(Gülke et al., 2001).    
In a study by Sundriyal et al., 2009, it has been shown that AAs E-428, E-430, S-388 
and R-345 had significant role in the catalytic activity of CDTa and mutations in these 
residues inhibited or decreased the cytotoxic activity of CDT. 
he N- and C-terminal of CDTa (Figure 10) are both  composed of five α-helices and 
eight β-strands . The two domains are almost perpendicular to each other but they 
face towards the same direction. Apart from the ADP-ribosyl turn-turn (ARTT) loop, 
Figure 9: ADP-ribosylation of an Arginine bound protein2 
Possible mechanism of ADP-ribosylation of Argine 177 residue of actin is presented. 
CDTa bonds NAD into its active site and mono-ADP-ribosylates the Arginine side chain 
of residue 177 on actin resulting in inactive protein. The reaction leads to the release of 
nicotinamide. 
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the overall structure looks very similar to that of the iota toxin. R-295, R-296, R-352, 
Q-300, N-335, E-378 and E-380 are the AAs in Ia that are important in its ADP-
ribosylating activity. These residues are in accordance and conserved with R-302, R-
303, R-359, Q-307, N-342, E-385 and E-387 in CDTa.  
 
 
Figure 10: 3D structure of CDTa and its sequence homology to other binary toxins (Sundriyal et al., 2009) 
A: the structure of CDTa includes a C-terminal and N-terminal composed of five α-helices and eight β-strands. 
The catalytic domain is bound with NAD that is shown in stick representation.  
B: a close analogy exists between the amino acid sequences of different clostridial and Bacillus binary toxin. 
Amino acid residues that are common in the sequence of each catalytic domain have been labeled by red. The 
comparison is made between C. difficile CDTa, C. perfringens E Ia, C. botulinum C2 and Bacillus cereus VIP2.  
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It is known that the NAD molecule interacts with R-302, R-303, R-359, Q-307, N-
342 and S-345 in a ‘closed conformation’ state (Figure 11). The binding AAs show 
different pattern in Ia with E-380, R-295, R-296, Q-300, R-352 and N-335 being the 
binding residues (Figure 11). S-345 is suggested to play an important role by directly 
interacting with the ligand in both complex structures containing NAD and NADPH. 
The differences of the AAs in Ia and CDT show that even though the two 
corresponding toxins are very homologous, they follow different modes of ligand 
recognition (Sundriyal et al., 2009).  
 
	  
Figure 11: NAD binding sites on CDTa and Ia (Sundriyal et al., 2009) 
The NAD molecule binds CDTa (figure above) and Ia (figure below) at a specific catalytic domain that is 
controlled by six different amino acid residues. In CDTa R-303 attracts the oxygen and amine of nicotineamide 
while, R-302 attracts the oxygen of α phosphate, R-359 attracts the oxygen and hydroxyl groups of β phosphate, S-
345 attracts aromatic hydroxyl of C2 in the pentose ribose sugar, N-342 attracts the amine and Q-307 attracts a 
hydroxyl group of the ribose pentose sugar. Similarly in Ia binding of NAD, R-296, R-295, R-352 and Q-300 do 
the same as R-303, R-302, R-359 and Q-307 in CDTa while, N-335 attracts both the amine and another N group in 
the adenine ring. Overall, the mechanism of binding between the catalytic site and the NAD molecule is very 
similar in both toxins.    
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2.7	  Toxinotyping	  of	  C.	  difficile	  isolates	  
Rupnik et al., 1998 has developed a method for toxinotyping of CD isolates (Figure 
12). In this method parts of the toxin genes (tcdA and tcdB) were amplified by PCR. 
The fragments were run for length polymorphism and cut with various restriction 
enzymes to monitor restriction fragment length polymorphism (RFLP).  
Around one fifth of the strains show differences in their toxin genes in comparison to 
the reference strain VPI 10463. Polymorphism was observed in both toxin genes.  
tcdB show a higher frequency of RFLP where a single restriction enzyme has 
sometimes given five different patterns. In the case of tcdA the restriction sites are 
more homogeneous where only two different RFLPs have been recognized for most 
enzymes.   
The strains are divided into 10 different groups of toxinotypes (I to X). Strains of the 
same toxinotype show similar forms of diversity in the toxin genes tcdA and tcdB and 
also for other regions of the PaLoc. Moreover a similar pattern of pulsed field gel 
electrophoresis is observed for strains of the same group.  
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Figure 12: toxinotyping of C. difficile isolates based on RFLP analysis of PaLoc genes (Rupnik et al., 1998) 
A: Toxinotype 0 (strain VPI) has intact genes of tcdA, tcdB, tcdC, tcdD and tcdE in comparison to other 
toxinotypes (I to X). As mentioned before (Chapter 2.3), there are repetitive sequences known as CROPs in both 
tcdA and tcdB where these regions are hatched in the figure. 
B: description of length and restriction site polymorphism in toxinotypes other than 0. Gray areas indicate length 
polymorphism. Deletions (?) are detected in A3 fragments of toxinotypes I, II, VI, VII and VIII whereas insertion 
in various fragments is detected in toxinotypes IV to X. The restriction enzymes are: A, AccI; Ec, EcoRV; E, 
EcoRI; H, HindIII; Hc, HincII; h, HaeIII; N, NsiI; Nc, NcoI; P, PstI; R, RsaI; S, SpeI. The restriction enzymes 
indicate only some of the restriction sites tested in each PCR fragment and not all the restriction sites of the same 
enzyme are shown. 
Note: C. difficile isolates of the epidemic hypervirulent ribotype 027 (NAP1) have alteration type ?117 with 18 
bp deletion in the negative regulator gene tcdC but they are however classified as toxinotype III isolates (Martin et 
al., 2008). 
 
2.8	  Characteristics	  of	  the	  CD	  027/NAP1	  strain	  
Albeit, being somewhat similar to the previously described strains of CD, 027 shows 
16 fold more activity of TcdA and 23 fold more activity of TcdB in vitro (Section 1). 
The dramatic increase in activity of the two toxins, along with the ADP-ribosylation 
of G-actin of CDT, has made the CDAD of 027 more severe, frequent, resistant and 
mortal than previously known. Although the role of increased production of TcdA and 
TcdB seems more dominant in the hypervirulence of 027 than the expression of CDT, 
it is possible that CDT plays an additional role by exacerbating the effect of the other 
two toxins. In order to understand the role of CDT in the pathogenesis of CDAD it is 
important to fully comprehend all different characteristics and factors in 027 that may 
play a role in the pathogenesis of CDAD by 027. 
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In CD 027, a 18 bp deletion in the negative regulator tcdC causes a frame shift 
mutation which may diminish the role of TcdC in down-regulation of TcdA and TcdB 
and production of the ADP-ribosylating toxin CDT. 027 is classified as toxinotype III 
(Martin et al., 2008).  
Another interesting feature associated with 027 is its resistance to fluoroquinolones 
such as gatifloxacin and moxifloxacin. This feature enables 027 to be resistant and 
have a survival tendency in hospital settings where fluoroquinolones are widely 
administered. Moreover, spores of CD are resistant to ethanol used for cleaning in 
hospitals (Pépin et al., 2005; McDonald et al., 2005: Blossom and McDonald, 2007).  
It has been established that TcdB has 10 times more toxicity in damaging the 
epithelium in human colonic explants in comparison to TcdA (Riegler et al., 1995). 
The overall description of the pathogenesis characteristics of 027 shows that its 
hypervirulence is associated with its different virulence factors: truncation of tcdC 
and presence of CDT, but in order to asses the role of CDT, a comparison of different 
studies on animal or human models is necessary. 
 
3.	  Aim	  
Evaluate the role of the binary CD toxin in the pathogenesis of CDAD. 
 
Comparing the in vivo pathogenicity of CD strains that do not produce CDT to the 
strains that do produce CDT should elucidate on the role of CDT in the pathogenesis 
of CDAD.  
As CDT shows similar patterns in structure, genetics and mechanism of action to 
other Bacillus and Clostridial binary toxins it may be assumed that the role of CDT in 
the pathogenesis of a disease is similar to other toxins such as C. perfringens iota.  
Despite the fact that the aim of this project is to evaluate the role of CDT in the 
pathogenesis of CDAD, it is important to note that the presence of CDT in the newly 
emerged hypervirulent CD 027 is the major motive in evaluating its role in the 
pathogenesis of CDAD.  
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4.	  Results	  and	  discussion	  	   	  
 
4.1	  Role	  of	  CDT	  in	  the	  pathogenesis	  of	  CDAD	  
A study performed by Barbut et al. (2005) showed that the diarrhea associated with 
CD of a CDT producing strain was more related to the community-acquired diarrhea 
and abdominal pains than the diarrhea caused by CDT-negative diarrhea. Moreover, 
the diarrhea caused by the CDT producing strain was more likely to be the reason of 
hospitalization of patients, demonstrating its severity. It has therefore been concluded 
that CDT could be an additional virulence factor, to toxins A and B, and related to the 
more severe forms of CDAD. Albeit, it is stated that this evaluation needs to be 
supported by specific clinical studies that would confirm the hypothesis that CDT 
production would increase the severity of CDAD. 
The exact role of CDT in the pathogenesis of CDAD is ambiguous at the moment. In 
other words, its role is not as clear as the role of TcdA and TcdB in the pathogenesis 
of CDAD or the role of other Clostridial binary toxins in pathogenesis of their 
associated disease. Although there are studies that have tried to evaluate the role of 
CDT in the pathogenesis of CDAD through experimental means (such as animal 
models), it is disputable that these findings are valid and useful in the case of 027. 
This is because, as mentioned before 027 has additional virulence factors such as a 
truncated tcdC and the hyper-production of TcdA and TcdB that makes it rather 
complicated to differentiate and elucidate the exclusive role of CDT in the 
pathogenesis of its associated disease at the moment (section 2.8). 
Geric et al., 2006 have shown an experimental approach to the role of CDT in the 
pathogenesis of CDAD in animals. The method, results and discussion of this study 
are summarized below. 
  
4.1.1	  Testing	  of	  TcdA-­‐	  TcdB-­‐	  CDT+	  CD	  strains	  in	  vivo	  
Four different strains of CD with TcdA- TcdB- CDT+ were isolated from different 
origins and their toxinotypes were confirmed by Polymerase Chain Reaction (PCR) 
and restriction enzyme analysis of the PaLoc. The primers described by Rupnik et al., 
1998 (Figure 12) were used for the PCR with two additional fragments Lok1 and 
Lok3 located outside the PaLoc (Braun et al., 1996) to verify the absence of PaLoc. 
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The results of PCR were confirmed by southern blot hybridization by probes F25 and 
5660 for regions in the 3’ of tcdA and tcdB (Table 1) (Sambol et al., 2000). 
Furthermore, Restriction Endonuclease Assay (REA) typing was also used to deduce 
the relatedness where isolates with similar or identical REA groups were determined 
for each strain (Table 1). Absence of TcdA and TcdB production was confirmed using 
immunoassay and standard cell culture assay. On the other hand, the production of 
CDT was verified by western blot assay and polyclonal antibodies of the iota toxin 
components as described before by Perelle et al., 1997. Further experimental 
procedures in determination of the role of trypsinization in the growth culture on the 
production of CDT were also done.  
The four CD isolates were grown at 37 °C in brain-heart infusion dialysis sacs for 
four days similar to the method used by Lyerly et al., 1985. Thereafter, ammonium 
sulfate (70%) was added to the supernatants and after four hours at 4 °C, precipitation 
occurred giving a 10 fold more concentrated supernatant. The samples were then 
dialyzed in 10 mmol/L of Tris buffer (pH = 7.5) in order to separate the residual 
ammonium sulfate. After dispensation through a filter, the samples were stored under 
nitrogen at 4 °C. After addition of trypsin to the aliquots for activation of CDTb, the 
samples were again concentrated 10 fold at 4 °C. The prepared solution was used as 
the test sample in injection to Rabbit ileal loops. 
Similar to the method by Sarker et al., 1999, white rabbit with an age of more than 12 
weeks underwent laparotomy where the ileum was identified. In each rabbit 7 ileal 
loop segments of size 7-10 cm was constructed using ligatures. Each one of these loop 
segments was inoculated by 500 µl of the test sample prepared before containing 450 
µl of the 100 times concentrated culture fluid. Furthermore, control samples for 
comparison were also tested. In this context, 500 µl of non-concentrated, non-
trypsinized filtered supernatant from CD VPI 10463 strain (TcdA+ TcdB+ CDT-) was 
used as the positive control. Moreover, two negative controls (TcdA- TcdB- CDT-) 
from strains 11186 and PBS were prepared by the same method as the other 4 tested 
samples explained before. The supernatant of each isolate was tested in four loop 
segments. After placing the ileum back to the abdominal cavity, the abdomen was 
closed. Sixteen hours later, the rabbits were killed and the ileum was removed from 
all rabbits. The volume of fluid and length of each ileal loop segments was measured 
(Table 1 and Figure 13). Volume to length ratios of more than 0.3 suggested 
enterotoxic activity by the tested samples. 
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In addition to the ileal loops assay in rabbit, a hamster challenge assay was developed 
(Sambol et al., 2001). In this context, the susceptibility of hamsters, inoculated by 
TcdA- TcdB- CDT+ strain, to treatments with clindamycin was tested. Young, adult 
Syrian golden hamsters weighing between 90-100 g were used in the experiment. 
Before treatment and inoculation, all hamsters were checked for any previous CD 
colonization in order to rule out any further complication in the results. Using 
orogastric method, each hamster received a single dose of clindamycin (30 mg/kg) 
five days before inoculation with CD spores. Then using intragastric method, 100 
CFU of each CD strain was administered for each hamster in a group of 10.  
CD strain 832 (TcdA+ TcdB+ CDT-, REA type B1 and toxinotype 0) was also 
administered to two hamsters in order to serve as positive controls. The strains of this 
REA type have been affiliated with high rates of CDAD in comparison to asymptotic 
colonization by other strains in human, furthermore, this particular strain (832) has 
proven to be highly virulent in this experiment (Figure 14) (Geric et al., 2006). 
Clindamycin was given two hamsters but not colonized with CD strains in order to 
serve as negative controls. Moreover, two hamsters without administration of 
clindamycin or colonization with CD were also selected. 
The tested hamsters were then monitored for 3-4 weeks for onset, duration and 
outcome of colonization or any other symptoms (Table 1 and figure 14). Furthermore, 
the cecal contents of 3 or 4 hamsters in each group were removed at the end of 
observation period and tested using TCCFA (taurocholate, cycloserine, cefoxitin, and 
fructose agar) to isolate the CD strain and confirm the colonization using REA typing 
and toxinotyping. 
 
Table 1: Molecular characterization of the four TcdA- TcdB- CDT+ isolates and the overall results of ileal 
loop and hamster challenge experiments (Geric et al., 2006) 
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Each isolate was isolated from a different origin stated, furthermore, REA type and toxinotyping by Restriction 
enzymes results for each isolates (using primers from Rupnik et al., 1998) is stated along with the deduced 
toxinotypes. The results of molecular characterization are in accordance to expectations. Note that, strain 6009 has 
an entirely different REA and a ghost PaLoc. Southern blot hybridization results indicate absence or presence of 
each toxin genes. The final results of V:L ratio  in ileal loop segments inoculated with each strain (along with the 
standard deviation) in each case, indicate an obvious enterotoxic activity that would be mentioned later (Figure 
13). Furthermore, all hamster (excluding the non-tested 3126 strain) inoculated with CD strains have colonized CD 
but no disease symptoms were manifested during the monitored period in any of hamsters (Figure 14).    
 
 
Figure 13: the results of rabbit ileal loops assay, V: L of ileal loop segment (mean ± SD) (Geric et al., 2006) 
A: Where a volume to length ratio of less than 0.3 in ileal loop segments would indicate non-enterotoxic response, 
it is fairly obvious that all rabbit ileal loop segments inoculated with the three TcdA- TcdB- CDT+ CD samples 
(3126, R11402 and 6009) show enterotoxic response. The two TcdA- TcdB- CDT- control samples (11186 and 
PBS) induce virtually no enterotoxic response in ileal loop segment of the inoculated rabbits while the highly 
enterotoxic TcdA+ TcdB+ CDT- control (VP 10463) also induces a strong enterotoxic response in the ileal loop 
segment of its inoculated rabbit. According to Geric et al., 2006, the enterotoxic response in the ileal loop 
segments of rabbits inoculated with TcdA- TcdB- CDT+ included non-hemorrhagic fluid accumulations where the 
fluids were watery, pale brown, and moderately clear whereas the fluids were extremely hemorrhagic in the ileal 
loop segment of rabbits inoculated with TcdA+ TcdB+ CDT- control (VP 10463). 
B: the extracted fluid from ileal loop segments of rabbits inoculated with TcdA- TcdB- CDT+ strain IS58 was 
incubated with the supernatant of antitoxins of C. perfringens E strain NCIB 10748 (anti-CpE, 0.1 ± 0 ml) and 
with that of C. spiroforme strain NCTC 11493 (anti-Csp, 0.5 ± 0 ml). The results clearly showed a partial 
neutralization of the enterotoxic response especially in treatments with anti-CpE (highlighting closer similarity 
between the iota toxin and CDT compared to CST). Furthermore, they indicate that the fluid accumulation and 
enterotoxic response was mostly due to the activity of CDT. 
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Figure 14: hamster challenge with C. difficile infection (Geric et al., 2006) 
Five days after administration of clindamycin, 10 hamsters in each group were inoculated with each TcdA- TcdB- 
CDT+ CD strain (R11402, 1S58 and 6009). A culture of fecal sample was tested by TCCFA in order to verify the 
status gut flora. When small violaceous colonies were detected the presence of normal gut flora was confirmed and 
when the gut flora was altered the test of fecal cultures with TCCFA gave completely negative results. The 
detection of CD colonization was made using the method described before. Furthermore, CD strain 832 with 
TcdA+ TcdB+ CDT- toxin production was used as control. 
The results indicate that C. difficile TcdA- TcdB- CDT+ strains were colonized in 70-80% of hamsters at the end of 
monitoring period. The onset of colonization was different in each hamster. Similar pattern in colonization onset 
was detected for hamsters inoculated with strain 6009 (TcdA- TcdB- CDT+) and the control 832 strain (TcdA+ 
TcdB+ CDT-) with earlier colonization of CD in comparison two other two the other two TcdA- TcdB- CDT+ 
strains (R11402 and 1S58). Moreover, similar susceptibility to clindamycin was observed for all 3 TcdA- TcdB- 
CDT+ strains where Minimum Inhibitory Concentration (MIC) at 24 and 48 h after clindamycin treatment was 1.5 
and 2.0 mg/ml for R11402, 0.5 and 1.0 mg/ml for IS58 and 2.0 and 2.0 mg/ml for 6009. MIC value for the control 
strain 832 was 1256 mg/ml shown. Intriguingly, none of the hamsters inoculated with TcdA- TcdB- CDT+ died or 
showed any symptoms of the disease during the observation period. On the other hand, both hamsters inoculated 
with the virulent TcdA+ TcdB+ CDT- 832 strain died shortly afterwards. Cecal tissue removed from these dead 
hamsters revealed extensive mucosal hemorrhage and infiltration with polymorphonuclear leucocytes.   
 
The results of the ileal loop assay indicate that the inoculation of rabbits by TcdA- 
TcdB- CDT+ strain causes fluid secretion due to the enterotoxic activity of CDT, the 
veracity of which was confirmed by the partial neutralization of the enterotoxic 
activity where antitoxins of C. perfringens E iota and C. spiroforme CST partially 
neutralized the enterotoxic effect of CDT.  
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Furthermore, while non-hemorrhagic fluid was accumulated in ileal loop segments of 
rabbit inoculated with TcdA- TcdB- CDT+ strains, extremely hemorrhagic fluid was 
accumulated in ileal loop segments of rabbit inoculated by TcdA+ TcdB+ CDT-. This 
difference in fluid response indicates that albeit CDT causes enterotoxic activity in 
rabbits, the enterotoxic activity caused by TcdA and TcdB is more severe and 
contributes more significantly to the symptoms of the disease.  
It is known that the enterotoxic activity of TcdA contributes more damage than TcdB 
and the intragastric administration of TcdA to hamsters causes diarrhea and death 
(Lyerly et al., 1985). In contrast TcdB is shown to be more potent in damaging the 
human colonic epithelium in vitro (Riegler et al., 1995).  
Nonetheless, it may be more instrumental to experiment the illeal loop assay using 
TcdA+ TcdB+ CDT+ and TcdA+ TcdB+ CDT- strains to be able to evaluate the 
contribution of CDT in the pathogenesis of CDAD in rabbits. This is something that 
has not been done in the illeal loop assay by Geric et al., 2006. 
On the other hand, the hamster challenge assay indicated that CDT is non-pathogenic 
in hamsters. However, most hamsters (70-80%) were colonized with CD in the end.  
In contrast, inoculation of hamsters by TcdA+ TcdB+ CDT- strain 832 caused a sudden 
death, indicating the great role of the other two toxins in the pathogenesis of CDAD.  
Furthermore, treatments with clindamycin disrupt the intestinal bacterial flora and 
create a favorable condition for colonization with CD (Geric et al., 2006). 
As stated before, the CD TcdA- TcdB- CDT+ test samples in the rabbit ileal loops 
assay were concentrated 100 fold and activated by trypsin, something that was not 
done in the case of the hamster challenge. It is therefore possible that the TcdA- TcdB- 
CDT+ strains used to inoculate hamsters did not produce enough of CDT to cause any 
significant disease (Geric et al., 2006). 
It is also important to remember that while the Syrian golden hamster is thought to be 
closely related to the human model in the case of susceptibility to infection as a result 
of antimicrobial administration (Sambol et al., 2001), there are some very important 
differences. In this context hamster are much more sensitive to the toxins and are 
killed following exposure (like in the case of CD strain 832 TcdA+ TcdB+ CDT-), 
while in humans even in the case of severe CD, mortality is less common. This may 
possibly be attributed to the presence of preexisting antibodies to CD toxins in 
humans (Kyne et al. 2000). 
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These differences could indicate a different role of CDT in the pathogenesis of CD in 
humans and animals.  
Another important point is that 027 exhibits extreme pathogenic and epidemic 
behavior due to a combination of virulence factors. This combination is absent in the 
strains tested in the animal model experiment (Geric et al., 2006). As mentioned 
before, the widespread administration of broad-spectrum antibiotics to patients in 
hospitals disrupts the intestinal flora and creates a favorable condition for colonization 
of CD. Moreover, a truncated tcdC may lead to diminished role of TcdC in down-
regulation of TcdA and TcdB and the production of CDT is the other possible virulent 
factor. Most importantly both TcdA and TcdB are produced in much higher 
concentrations (16 times for TcdA and 23 times for TcdB). The increase in production 
of these two toxins may be attributed to either a truncated tcdC or CDT production or 
a combination of both.  
Another hypothesis on the role of CDT is that it may enhance the effect of elevated 
levels of TcdA and TcdB. It has been shown that CDT increases the adherence of 
bacterial cells to the intestinal epithelium by inducing microtubule-based protrusions 
on the cell surface. Microtubules are one of the essential components of cytoskeleton 
in the cell. CDT causes a redistribution of microtubules and formation of long cellular 
microtubule-based protrusions that act as a dense network for wrapping of bacterial 
cells. Furthermore, similar effect was shown to be accomplished by C. botulinum C2 
and C. perfringens iota toxin (Schwan et al., 2009). These findings suggest a 
significant role for CDT in interaction and/or colonization of CD. The role of CDT in 
colonization of CD was also proved in hamsters using TcdA- TcdB- CDT+ strain but it 
was more ideal if Geric et al., 2006 tested CDT+ strains in absence of antibiotics and 
asses that to what extent is CDT involved in colonization of CD by itself. 
On the other hand, the hamster challenge assay also displayed a successful (70-80%) 
colonization of CD in hamsters inoculated with TcdA- TcdB- CDT+ strains but no 
symptom of CDAD. This leads to the conclusion that CDT may play a role in 
adherence and/or colonization of CD in addition to its own toxic activity but in the 
absence of TcdA and TcdB, not significant disease arises. In contrast, this feature 
demonstrated by CDT in addition to elevated production of TcdA and TcdB in 027 
may constitute the essential reason for pathogenesis and hypervirulence of that strain.  
Another possible, yet unproven, hypothesis for the role of CDT in the pathogenesis of 
CDAD may be attributed to the binding component CDTb that may also be capable of 
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facilitating the transportation or improved interaction of TcdA and TcdB to the target 
cells. Binary toxins such as CDT are also shown to be effective for the transport of 
drugs into eukaryotic cells (Barth and Stiles, 2008). 
It does also seem more logical to consider the truncated tcdC in 027 as the actual 
reason for elevated production of TcdA and TcdB that is also in accordance to what 
was described in the theory (section 2.2). In vivo experiments in animals using tcdC-
truncated CD strains may clarify the actual role of tcdC in pathogenesis of 027. 
Another important point in consideration of 027 is the role of CDT in recurrence, 
resistance and severity of its associated disease. It is a fair assumption to consider 
CDT as a reason for association of the epithelial cells with CD. In other words, CDT 
may make it more difficult to eradicate the disease because of creating a favorable 
interaction of CD cells with the host epithelial cells. This may also be an essential 
parameter in recurrence, resistance and severity of CDAD. Moreover, 
fluoroquinolones and ethanol enhance the colonization and resistance of CD. 
 
4.2	  The	  role	  of	  other	  binary	  toxins	  in	  the	  pathogenesis	  of	  their	  
associated	  diseases	  
It has been shown that the iota toxin in C. perfringens type E causes enterotoxaemia 
in lambs, calves and rabbits (Songer, 1996). It has been shown that the iota toxin 
induces hemorrhagic and necrotic enteritis in neonatal calves (Billington et al., 1998). 
C. spiroforme CST toxin is another binary toxin with similarities to CDT that has 
been shown to cause enterotoxaemia in rabbits and other laboratory rodents. 
Furthermore, the toxin is lethal in mice and necrotic guinea pigs. C. spiroforme also 
causes spontaneous diarrhea in weaned rabbits. Administration of antibiotics and 
weaning provides proper condition for the toxic activity of CST as they both disrupt 
the bowel flora (Songer, 1996). C. spiroforme CST has been shown to induce fatal 
disease in antibiotic treated hamsters (Carman et al., 1989). 
The consensus agreement on the positive role of these toxins on the pathogenesis of 
associated diseases in animals may be useful (but not tangible) in drawing 
conclusions about the role of CDT in the pathogenesis of CDAD, as there are 
similarities in structure, function and mechanism of action in all of these binary 
toxins. 
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5.	  Conclusion	  
In the absence of TcdA and TcdB, CDT induces enterotoxic response in rabbits while 
it appears to be non-pathogenic in hamsters. Nonetheless, CDT induces the 
colonization of CD in hamsters.  
Even though the observations in the animal model studies are inconclusive, it is 
reasonable to conclude, however, that CDT may play a potential supplementary role 
in the pathogenesis of CDAD by CD 027. This is supported by the fact that CDT 
induces favorable interaction of CD bacterial cells to the intestinal epithelium and 
may thereby enhance the toxic effects of TcdA and TcdB. 
It is, however, important to note that the role of CDT in the pathogenesis of 027 
cannot be distinguished from other virulence factors such as the truncated tcdC gene. 
It is possible to conclude that a truncated tcdC leads to much higher production of 
TcdA and TcdB while the presence of CDT enhances the colonization of CD and/or 
facilitates the interaction of the other two toxins with the target cells. Such activities 
by CDT would enhance the toxicity of TcdA and TcdB but cause non-pathogenic 
response in their absence (like in the case of hamsters). 
Future studies on the role of CDT are necessary to formulate a final and absolute 
conclusion. These studies may involve in vivo experiments on animals using TcdA+ 
TcdB+ CDT- and TcdA+ TcdB+ CDT+ in order to compare the role of CDT by itself or 
in combination with the other two toxins in the pathogenesis of the disease. 
Furthermore, studies on more interaction of other toxins with target cells induced by 
CDT are also instrumental in clarification of the exact mechanism of this binary toxin 
in the pathogenesis of CDAD. 
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